|
Eugene pregunto:
Have you got any experience? <a href=" http://www.wout.nl/portfolio/de-oude-tijd-2/ ">xplozion amazon</a> The drug - licensed from U.S. biotech firm Oncothyreon - will be tested on patients with locally advanced Stage III non-small cell lung cancer (NSCLC), which cannot be surgically removed, unchanged from the previous trial called START, the firm said. |
|
|
|
